Consequently, relying solely on individual molecules for predicting the course of COVID‐19 remains insufficient, and whether the diagnostic efficiency of predicting COVID‐19 severity can be improved by the combined assessment of HBP, IL‐6, and CRP is currently unknown. Here, IL6 is linked to COVID-19.